Full-scan Mass Spectral Evidence for 3-epi-25-hydroxyvitamin D₃ in Serum of Infants and Adults
Overview
Pathology
Affiliations
Background: Since the introduction of liquid chromatography-mass spectrometry (LC/MS) for assessing vitamin D status, it has been shown that the C-3 epimer can account for a significant proportion of circulating 25-hydroxyvitamin D₃ (25OHD₃) concentrations in infants. However, some question whether monitoring a single MS transition at a chromatographic retention time typical for 3-epi-25OHD₃ sufficiently warrants conclusions about the identity of the substance generating the signal. Therefore, we aimed to substantiate the evidence for 3-epi-25OHD₃ in infants by collision induced dissociation (CID)-MS/MS product ion scans. A second objective was mass spectrometric investigation of the presence and prevalence of the 3-epi metabolite in serum from adults.
Methods: Serum samples from six infants and 32 adults were studied using an ultra performance LC/tandem MS (UPLC/MS/MS) method designed to separate the 3-epi-25OHD₃ from 25OHD₃. Samples were submitted to liquid/liquid extraction and Sephadex LH-20 fractionation, prior to column-switching UPLC with MS/MS recording of CID product ion spectra of the [M+H](+) precursor ion. The respective standards were analyzed under identical UPLC/MS/MS conditions for comparison.
Results: In the chromatograms of all samples, two peaks eluted with retention characteristics and spectra closely matching those observed for the 25OHD₃ and the 3-epi standards. The percentage of the 3-epi metabolite relative to 25OHD₃ in infants ranged from 15% to 41%, and in adults from 2.5% to 17%.
Conclusions: This preliminary finding suggests that the prevalence of 3-epi-25OHD₃ in serum of infants is considerable, and that even in adults the concentrations of this form should not be neglected.
Evolution and impact of Standard Reference Materials (SRMs) for determining vitamin D metabolites.
Wise S, Kuszak A, Camara J Anal Bioanal Chem. 2024; 416(9):2335-2358.
PMID: 38236394 DOI: 10.1007/s00216-024-05143-w.
Kimsa-Furdzik M, Bednarek A, Hibner G, Czajka-Francuz P, Cison-Jurek S, Karawasiecka D Metabolites. 2023; 13(9).
PMID: 37755276 PMC: 10534610. DOI: 10.3390/metabo13090996.
Vitamin D: marker, measurand & measurement.
Dirks N, Cavalier E, Heijboer A Endocr Connect. 2023; 12(4).
PMID: 36688810 PMC: 10083657. DOI: 10.1530/EC-22-0269.
Makris K, Bhattoa H, Cavalier E, Phinney K, Sempos C, Ulmer C Clin Chim Acta. 2021; 517:171-197.
PMID: 33713690 PMC: 8080555. DOI: 10.1016/j.cca.2021.03.002.
Update of the tolerable upper intake level for vitamin D for infants.
Turck D, Bresson J, Burlingame B, Dean T, Fairweather-Tait S, Heinonen M EFSA J. 2020; 16(8):e05365.
PMID: 32626014 PMC: 7009676. DOI: 10.2903/j.efsa.2018.5365.